Necrobiotic xanthogranuloma successfully treated with autologous stem cell transplantation

Annals of Hematology
|January 12, 2007
PubMed

Insights

Necrobiotic xanthogranuloma, a rare complication of paraproteinemia, can cause severe vision loss. High-dose chemotherapy and autologous stem cell transplantation offer a promising, curative treatment for this progressive condition.

Area of Science:

  • Oncology
  • Hematology
  • Dermatology

Background:

  • Necrobiotic xanthogranuloma is a rare, progressive granulomatous disease often associated with paraproteinemia.
  • Limited therapeutic options and lack of consensus on treatment strategies pose challenges.

Observation:

  • A patient presented with massive periorbital infiltration of necrobiotic xanthogranuloma, causing significant visual impairment.
  • Conventional therapies for multiple myeloma provided only minimal relief.

Findings:

  • The patient achieved complete symptom remission following high-dose chemotherapy and autologous stem cell transplantation.
  • This represents the first documented success of autologous stem cell transplantation for necrobiotic xanthogranuloma.

Implications:

  • Autologous stem cell transplantation is a viable and potentially curative therapeutic option for severe necrobiotic xanthogranuloma.
  • This case expands treatment possibilities for patients with refractory disease and paraproteinemia.